Chronic conjunctivitis

Summary

Chronic conjunctivitis (MONDO:0002314) is a disease (an umbrella term covering 5 Mondo subtypes) and 1 clinical trial. A subtype of conjunctivitis — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Umbrella term: 5 Mondo subtypes
• Clinical trials: 1

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	chronic conjunctivitis
Mondo ID	MONDO:0002314
DOID	DOID:2475
ICD-10-CM	H10.4
ICD-11	1548498139
NCIT	C35197
SNOMED CT	73762008
UMLS	C0155145
MedGen	102326
Is cancer (heuristic)	no

Also known as: chronic conjunctivitis · chronic conjunctivitis (disease) · chronic conjunctivitis, unspecified · conjunctivitis (disease), chronic

Disease family

This is a subtype of conjunctivitis. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › disorder of orbital region › eye adnexa disorder › conjunctival disorder › conjunctivitis › chronic conjunctivitis

Related subtypes (7): acute conjunctivitis, blepharoconjunctivitis, papillary conjunctivitis, keratoconjunctivitis, rosacea conjunctivitis, bacterial conjunctivitis, viral conjunctivitis

Subtypes (5): chronic follicular conjunctivitis, parasitic conjunctivitis, vernal conjunctivitis, simple chronic conjunctivitis, atopic conjunctivitis

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 1.

Phase distribution (across all retrieved trials)

Phase	Trials
PHASE1/PHASE2	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT05520086	PHASE1/PHASE2	UNKNOWN	Clinical Trial to Evaluate Safety and Efficacy of Cell Therapy in Patients With Cicatricial Conjuntivitis.